SCHEMBL21494415

SCHEMBL21494415

CC(O)Cc1cc(Br)cnc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.33
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALOX15 P16050 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
PPARG P37231 1/20 0.31
KMT2A Q03164 1/20 0.31
NCOA2 Q15596 1/20 0.31
NCOA1 Q15788 1/20 0.31
NCOA3 Q9Y6Q9 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
NOS2 P35228 1/20 0.31
CCR5 P51681 1/20 0.31
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046239 0.77 KMT2A (0.35) PLAUS1PR1S1PR3MEN1MAPT
SCHEMBL21494328 0.77 GABRA1 (0.35) ALDH1A1NPSR1MAPTNPC1RAB9A
SCHEMBL1543624 0.76 PDXK (0.46) PLAUALDH1A1MEN1MAPTHPGD
SCHEMBL25233643 0.76 ALDH1A1 (0.39) PLAUS1PR1S1PR3ALDH1A1NPSR1
SCHEMBL31430877 0.74 KMT2A (0.37) PLAUALDH1A1NPSR1MEN1MAPT
SCHEMBL856508 0.74 KMT2A (0.37) PLAUALDH1A1NPSR1MEN1MAPT
SCHEMBL2968350 0.73 GABRA1 (0.36) PLAUS1PR1S1PR3ALDH1A1NPSR1
SCHEMBL28046023 0.72 CYP3A4 (0.36) PLAUALDH1A1NPSR1MEN1MAPT
SCHEMBL31254092 0.72 KCNJ5 (0.32) PLAU
SCHEMBL15052847 0.72 HTT (0.34) PLAUMEN1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3784671-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2021-03-03 EP disclosed
WO-2019201283-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS, INC. (US) 2019-10-24 WO disclosed